REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmamed Consulting & Investment S.R.L. (Romania)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: Pharmamed Consulting & Investment S.R.L. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmamed Consulting & Investment S.R.L. is an enterprise located in Romania, with the main office in VOLUNTARI. The enterprise currently operates in the All Other Professional, Scientific, and Technical Services sector. Pharmamed Consulting & Investment S.R.L. was incorporated on June 20, 2018. It currently has a total number of 2 (2025) employees. From the latest financial highlights, Pharmamed Consulting & Investment S.R.L. reported a net sales revenue drop of 32.62% in 2024. During that time, Pharmamed Consulting & Investment S.R.L.’s total assets grew by 0.74%. Pharmamed Consulting & Investment S.R.L.’s net profit margin increased by 11.77% in 2024.

Headquarters
Soseaua Bucuresti Nord Nr. 10
VOLUNTARI; Ilfov; Postal Code: 077190

Contact Details: Purchase the Pharmamed Consulting & Investment S.R.L. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmamed Consulting & Investment S.R.L. report to view the information.
Registered Capital:
Purchase the Pharmamed Consulting & Investment S.R.L. report to view the information.
Financial Auditors:
Purchase the Pharmamed Consulting & Investment S.R.L. report to view the information.
Incorporation Date:
June 20, 2018
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmamed Consulting & Investment S.R.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-32.62%
Total Operating Revenue
-31.38%
Operating Profit
9.88%
EBITDA
10.3%
Net Profit/Loss for the Period
6.22%
Total Assets
0.74%
Total Equity
5.86%
Operating Profit Margin
15.3%
Net Profit Margin
11.77%
Return on Equity (ROE)
0.34%
Quick Ratio
0.06%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?